Becker's Healthcare October 21, 2021
Maia Anderson

Six deals and acquisitions completed by drugmakers since the end of July, as reported by Becker’s Hospital Review:

  1. Merck plans to acquire Acceleron Pharma for about $11.5 billion to expand its rare disease drug portfolio.
  2. Sanofi will acquire New York City-based drugmaker Kadmon for $1.9 billion.
  3. Pfizer entered into a definitive agreement to...

Today's Sponsors

Qure4u
HLTH
ZeOmega

Today's Sponsors

Premier
TripleTree

Today's Sponsor

Transcarent

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
Elsevier acquires Osmosis to advance medical education portfolio
PE-Backed Fortis Purchases Select Home Health
5 recent health IT company acquisitions
Nordic Consulting acquires S&P Consultants, Expands Cerner Division to Meet Industry Demand
M&A: PE Firm Carlyle Acquires Health IT Solutions Provider CNSI